- Home
- XERS vs LPG Comparison
XERS vs LPG Comparison
Compare XERS & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | LPG |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XERS | LPG |
|---|---|---|
| Price | $13.32 | $49.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $12.86 | ★ $56.60 |
| AVG Volume (30 Days) | ★ 2.2M | 459.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.97% |
| EPS Growth | 100.00 | ★ 112.15 |
| EPS | N/A | ★ 8.22 |
| Revenue | $49,590,000.00 | ★ $481,511,242.00 |
| Revenue This Year | $32.91 | $45.52 |
| Revenue Next Year | $23.75 | N/A |
| P/E Ratio | ★ N/A | $15.26 |
| Revenue Growth | ★ 142.67 | 36.27 |
| 52 Week Low | $5.25 | $23.76 |
| 52 Week High | $11.42 | $59.97 |
Technical Indicators
Market Signals| Indicator | XERS | LPG |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 36.05 |
| Support Level | $9.73 | $47.50 |
| Resistance Level | $10.60 | $52.10 |
| Average True Range (ATR) | 0.48 | 2.05 |
| MACD | -0.09 | -0.48 |
| Stochastic Oscillator | 39.36 | 7.22 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.